Showing results (1-10 of 148) with videos related to
Sort By:
Pageof 15
Seminars in Liver Disease|June 1, 2014
Drug-induced nodular regenerative hyperplasiaMarwan Ghabril, Raj VuppalanchiHepatology (Baltimore, Md.)|December 10, 2008
Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: Selected practical issues in their evaluation and managementRaj Vuppalanchi, Naga ChalasaniCurrent Treatment Options in Cardiovascular Medicine|July 25, 2009
Use of statins in patients with liver diseaseSweta Tandra, Raj VuppalanchiAlimentary Pharmacology & Therapeutics|October 25, 2022
Review article: clinical assessment of suspected drug-induced liver injury and its managementRaj Vuppalanchi, Marwan GhabrilClinics in Liver Disease|October 18, 2025
Future Treatment Options for Managing Primary Sclerosing Cholangitis and Cholestatic PruritusTaranika Sarkar Das, Raj VuppalanchiClinics in Liver Disease|October 18, 2025
Recent Advances in Primary Biliary Cholangitis TreatmentTaranika Sarkar Das, Raj VuppalanchiThe American Journal of the Medical Sciences|February 16, 2005
Patients with elevated baseline liver enzymes do not have higher frequency of hepatotoxicity from lovastatin than those with normal baseline liver enzymesRaj Vuppalanchi, Evegenia Teal, Naga ChalasaniArchives of Pathology & Laboratory Medicine|July 1, 2015
Drug-Induced Liver InjuryKurt Fisher, Raj Vuppalanchi, Romil SaxenaSeminars in Liver Disease|March 16, 2012
Dyslipidemia in patients with nonalcoholic fatty liver diseaseHemant Chatrath, Raj Vuppalanchi, Naga ChalasaniThe American Journal of Surgical Pathology|November 24, 2006
Restoration of bile ducts in drug-induced vanishing bile duct syndrome due to zonisamideRaj Vuppalanchi, Naga Chalasani, Romil SaxenaPageof 15